ENERGENESIS BIOMEDICAL CO.,LTD. Funds and ETFs Energenesis Biomedical CO.,LTD.
Equities
6657
TW0006657000
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.6 TWD | +1.09% |
|
+3.73% | -7.95% |
| Apr. 08 | Energenesis Biomedical CO.,LTD. announced a financing transaction | CI |
| Feb. 29 | Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Energenesis Biomedical CO.,LTD.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +0.53% | - |
ENERGENESIS BIOMEDICAL CO., LTD. is mainly engaged in the research and development of new drugs. The Company's main product projects include experimental service analysis and reagent sales. The Company's main new drugs include ENERGI-F703, ENERGI-F701, ENERGI-F711, and ENERGI-F706. The ENERGI-F703 indications are diabetic foot ulcers. The ENERGI-F701 indications are abnormal alopecia. The ENERGI-F711 indications are burns. The ENERGI-F706 indications are cachexia.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.95% | 128M | |
| +0.63% | 42.86B | |
| +12.14% | 42.74B | |
| +44.30% | 41.36B | |
| -6.20% | 27.68B | |
| +5.90% | 25.15B | |
| -23.64% | 18.63B | |
| +28.35% | 12.37B | |
| -3.42% | 11.92B | |
| +7.04% | 11.21B |
- Stock Market
- Equities
- 6657 Stock
- Funds and ETFs Energenesis Biomedical CO.,LTD.
